These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6763881)
1. Immune reactivity of spleen cells in advanced stages of tumor growth. Oisgold-Dagá S; Jasnis MA; Klein S; de Bonaparte YP Biomed Pharmacother; 1982; 36(6-7):319-23. PubMed ID: 6763881 [TBL] [Abstract][Full Text] [Related]
2. Tumor delayed hypersensitivity reactions. "In vivo" functional differences between spleen and peripheral blood lymphocytes. de Bonaparte YP; Oisgold-Dagá S; Klein S; Stillitani-D'Elia I Biomedicine; 1980 Feb; 33(1):16-8. PubMed ID: 7370382 [TBL] [Abstract][Full Text] [Related]
3. Stimulation of mouse migration inhibitory factor (MIF) production form MSV-immune lymphocytes by soluble tumor-associated antigen: requirement for histocompatible macrophages. Landolfo S; Herberman RB; Holden HT J Immunol; 1977 Apr; 118(4):1244-8. PubMed ID: 191532 [TBL] [Abstract][Full Text] [Related]
4. Immune RNA-mediated transfer of tumor antigen responsiveness to unresponsive peritoneal exudate cells from tumor-bearing animals. Braun DP; Dray S Cancer Res; 1977 Nov; 37(11):4138-44. PubMed ID: 908048 [TBL] [Abstract][Full Text] [Related]
5. Cellular immunity to solubilized tumor antigens of a methylcholanthrene-induced sarcoma with a migration inhibition assay. Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW; Natori T; Law LW J Immunol; 1978 Jun; 120(6):1981-5. PubMed ID: 659888 [TBL] [Abstract][Full Text] [Related]
6. [Effect of the splenic cells of tumor-bearing mice on the allograft immune response]. Spasokukotskiĭ AL Vopr Onkol; 1985; 31(7):87-91. PubMed ID: 4024565 [TBL] [Abstract][Full Text] [Related]
7. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells. McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the macrophage electrophoretic mobility test and the leukocyte migration inhibition test in the detection of histocompatibility antigens on tumor cells. Bubeník J; Cochran AJ; Todd G; Malkovský M; Jandlová T; Suhajová E; Boubelík M Neoplasma; 1981; 28(2):185-93. PubMed ID: 7019742 [TBL] [Abstract][Full Text] [Related]
9. [Participation of spleen cells in regulating the production of macrophage migration inhibitory factor in mice]. Koval'chuk LV; Sotnikova NIu Biull Eksp Biol Med; 1981 Mar; 91(3):336-8. PubMed ID: 7018617 [TBL] [Abstract][Full Text] [Related]
10. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. Gabrilovich DI; Nadaf S; Corak J; Berzofsky JA; Carbone DP Cell Immunol; 1996 May; 170(1):111-9. PubMed ID: 8665591 [TBL] [Abstract][Full Text] [Related]
11. Apparent lack of immunogenicity of estrogen-induced testicular Leydig cell tumors in BALB/c mice. Huseby RA; Page RH Cancer Res; 1982 Nov; 42(11):4332-8. PubMed ID: 6751521 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Korbelik M; Dougherty GJ Cancer Res; 1999 Apr; 59(8):1941-6. PubMed ID: 10213504 [TBL] [Abstract][Full Text] [Related]
13. Cellular cytotoxicity and serum inhibition in normal mice following transfer of syngeneic tumor-sensitized cells. Fisher B; Wolmark N; Saffer EA J Natl Cancer Inst; 1980 Mar; 64(3):579-85. PubMed ID: 6986497 [TBL] [Abstract][Full Text] [Related]
14. Immune selection in murine tumors. Ph.d thesis. Svane IM; Engel AM APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251 [TBL] [Abstract][Full Text] [Related]
15. [Kinetics of production of macrophage migration inhibitory factors in mixed culture of lymphocytes and tumor cells]. Kharkevich DD; Suslov AP Biull Eksp Biol Med; 1982 Feb; 93(2):53-5. PubMed ID: 6461371 [No Abstract] [Full Text] [Related]
16. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state. Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900 [TBL] [Abstract][Full Text] [Related]
17. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice. Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316 [TBL] [Abstract][Full Text] [Related]
18. Evidence of dual function of macrophage migration inhibitory factor relevant to tumor progression and regression. Fukushima T; Nishihira J; Yoshiki T; Iwabuchi K; Iwabuchi C; Yamasaki Y; Kondo M; Sun B; Sato Y; Todo S Int J Mol Med; 2005 Jul; 16(1):119-26. PubMed ID: 15942688 [TBL] [Abstract][Full Text] [Related]
19. In vivo growth of transitional and renal cell carcinoma cell lines can be suppressed by the adenovirus-mediated expression of a soluble form of vascular endothelial growth factor receptor. Ichikura H; Eto M; Ueno H; Harada M; Takayama K; Tokuda N; Tatsugami K; Naito S Oncol Rep; 2006 May; 15(5):1333-7. PubMed ID: 16596207 [TBL] [Abstract][Full Text] [Related]
20. Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay. Borkowsky W; Suleski P; Bhardwaj N; Lawrence HS J Immunol; 1981 Jan; 126(1):80-2. PubMed ID: 6161170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]